Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

The Efficacy and Safety of Transcranial Photobiomodulation for Mild Cognitive Impairment Due to Alzheimer's Disease: A Randomized, Double-Blind, Sham-Controlled Study

Findings suggest that tPBM is an effective and safe home-use intervention for individuals with MCI, with promising therapeutic and preventative roles in Alzheimer's dementia.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors randomized 26 adults with mild cognitive impairment due to Alzheimer's disease to self-administered at-home transcranial photobiomodulation or sham for 12 weeks. The treatment group showed a statistically significant improvement in one cognitive test (K-MoCA) at week 13 compared with sham, while the MMSE2 change was not significant. No serious adverse events were reported.

Participants
26
Who or what was studied
Adults with mild cognitive impairment due to Alzheimer's disease (K-MMSE2 score 23-27, global CDR 0.5-1.0)
Limits stated in the abstract
The abstract reports a small sample of 26 participants and does not state wavelengths, so the conclusion that tPBM is effective and safe goes beyond what this limited trial can establish.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Transcranial photobiomodulation, Mild cognitive impairment, Photobiomodulation, Sham, Montreal Cognitive Assessment, Dementia, Adenosine triphosphate, Cerebral blood flow. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Brain & Neurology

Chronic 40-hz light-emitting diode (LED) therapy attenuates cognitive and behavioral deficits and modulates BDNF and caspase-3 expression in a D-galactose/aluminum chloride-induced sporadic Alzheimer's-like rat model

These data suggest that 40-Hz LED stimulation confers neuroprotection in the D-gal/AlCl3-induced AD model, potentially through enhancement of neurotropic signaling and inhibition of apoptosis, supporting its promise as a non-invasive strategy against neurodegenerative decline.

Study · August 7, 2026 · Ghorbani E et al.